Market Place
Sourcing Support
Wanbang Biopharms Generic Guanfacine Hydrochloride Receives Approval in US
12 Jun 2024 //
FDA
Xiromed`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
23 Feb 2024 //
FDA
Health Canada Issues Recall of JAMP Guanfacine XR 1 mg: Foreign tablets
14 Dec 2023 //
HEALTH CANADA
Alembic`s Generic Guanfacine Hydrochloride Receives Approval in the U.S.
07 Aug 2023 //
FDA
TWI Pharms`s Generic Guanfacine Hydrochloride Receives Approval in the US
08 Jun 2022 //
FDA
Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended
31 Mar 2021 //
PRNEWSWIRE
Unichem Labs Generic Guanfacine Hydrochloride Receives Approval in US
08 Mar 2021 //
FDA
Yichang Humanwell`s Generic Guanfacine Receives Approval in US
28 Nov 2020 //
FDA
Shionogi submits NDA for INTUNIV
21 Aug 2018 //
BIOSPECTRUM ASIA
Apotex`s Generic Guanfacine Hydrochloride Receives Approval in US
28 Jul 2018 //
FDA
Sun Pharm’s Generic Guanfacine Hydrochloride Receives Approval In US
17 Nov 2017 //
FDA
Shire, Shionogi`s ADHD drug for adults clears late-stage trial in Japan
20 Sep 2017 //
REUTERS
EMA to Continue to Allow Patient Involvement in CHMP Meetings
08 May 2017 //
RAPS
Shire`s ADHD Candidate`s NDA Accepted by FDA
20 Jan 2017 //
NASDAQ
Shire launches long-acting ADHD drug Intuniv in UK
09 Mar 2016 //
PM LIVE
Shire`s Intuniv (guanfacine) approved in EU for ADHD
06 Oct 2015 //
EMA
EU approves Shire`s long-acting ADHD drug
21 Sep 2015 //
PHARMATIMES
Mylan introduces generic Intuniv and Seasonique tablets in US markets
03 Jun 2015 //
PHARMABIZ
Health Canada issues “stronger, clearer” warnings about suicide risks linked to ADHD drugs
03 Apr 2015 //
THE STAR
ADHD Drugs May Increase Risk Of Suicidal Thoughts And Behaviours In Some People; Benefits Still Outweigh Risks
01 Apr 2015 //
HEALTHY CANADIANS
Free Trade Can Make Cancer Drugs Cheaper
18 Feb 2015 //
THE SALT LAKE TRIBUNE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.